Lung Cancer: Advances and Insights in Diagnosis, Treatment, and Palliation

Affiliations

Comment

Daniel J da Costa et al. Am J Respir Crit Care Med. 2018.

. 2018 Sep 1;198(5):667-669.

doi: 10.1164/rccm.201801-0107RR.

¹ Division of Respiratory and Critical Care Physiology and Medicine, Harbor-UCLA Medical Center, Torrance, California.

No abstract available

Comment on

Spectrum Analysis of Endobronchial Ultrasound Radiofrequency of Lymph Nodes in Patients With Lung Cancer.
Nakajima T, Shingyoji M, Anayama T, Kimura H, Yasufuku K, Yoshino I. Nakajima T, et al. Chest. 2016 Jun;149(6):1393-9. doi: 10.1016/j.chest.2016.01.015. Epub 2016 Jan 23. Chest. 2016. PMID: 26836932
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR; KEYNOTE-024 Investigators. Reck M, et al. N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718847 Clinical Trial.
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, Horwood FC, Piccolo F, Lam DCL, Garske LA, Shrestha R, Kosky C, Read CA, Murray K, Lee YCG. Thomas R, et al. JAMA. 2017 Nov 21;318(19):1903-1912. doi: 10.1001/jama.2017.17426. JAMA. 2017. PMID: 29164255 Free PMC article. Clinical Trial.